Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Metabolic Responses to Polymyxin Treatment in Acinetobacter baumannii ATCC 19606: Integrating Transcriptomics and Metabolomics with Genome-Scale Metabolic Modeling.

Zhu Y, Zhao J, Maifiah MHM, Velkov T, Schreiber F, Li J.

mSystems. 2019 Feb 5;4(1). pii: e00157-18. doi: 10.1128/mSystems.00157-18. eCollection 2019 Jan-Feb.

2.

Genome-scale metabolic modeling of responses to polymyxins in Pseudomonas aeruginosa.

Zhu Y, Czauderna T, Zhao J, Klapperstueck M, Maifiah MHM, Han ML, Lu J, Sommer B, Velkov T, Lithgow T, Song J, Schreiber F, Li J.

Gigascience. 2018 Apr 1;7(4). doi: 10.1093/gigascience/giy021.

3.

Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumannii.

Maifiah MH, Creek DJ, Nation RL, Forrest A, Tsuji BT, Velkov T, Li J.

Sci Rep. 2017 Mar 30;7:45527. doi: 10.1038/srep45527.

4.

Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii.

Maifiah MH, Cheah SE, Johnson MD, Han ML, Boyce JD, Thamlikitkul V, Forrest A, Kaye KS, Hertzog P, Purcell AW, Song J, Velkov T, Creek DJ, Li J.

Sci Rep. 2016 Feb 29;6:22287. doi: 10.1038/srep22287.

Supplemental Content

Loading ...
Support Center